1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Rotavirus Infection Therapeutics Revenue 1.4 Market Analysis by Type 1.4.1 Global Rotavirus Infection Therapeutics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Oral Drug 1.4.3 Injiectable Drug 1.5 Market by Application 1.5.1 Global Rotavirus Infection Therapeutics Market Share by Application: 2020 VS 2026 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.6 Coronavirus Disease 2019 (Covid-19): Rotavirus Infection Therapeutics Industry Impact 1.6.1 How the Covid-19 is Affecting the Rotavirus Infection Therapeutics Industry 1.6.1.1 Rotavirus Infection Therapeutics Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Rotavirus Infection Therapeutics Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Rotavirus Infection Therapeutics Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Rotavirus Infection Therapeutics Market Perspective (2015-2026) 2.2 Rotavirus Infection Therapeutics Growth Trends by Regions 2.2.1 Rotavirus Infection Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Rotavirus Infection Therapeutics Historic Market Share by Regions (2015-2020) 2.2.3 Rotavirus Infection Therapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Rotavirus Infection Therapeutics Market Growth Strategy 2.3.6 Primary Interviews with Key Rotavirus Infection Therapeutics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Rotavirus Infection Therapeutics Players by Market Size 3.1.1 Global Top Rotavirus Infection Therapeutics Players by Revenue (2015-2020) 3.1.2 Global Rotavirus Infection Therapeutics Revenue Market Share by Players (2015-2020) 3.1.3 Global Rotavirus Infection Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Rotavirus Infection Therapeutics Market Concentration Ratio 3.2.1 Global Rotavirus Infection Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Rotavirus Infection Therapeutics Revenue in 2019 3.3 Rotavirus Infection Therapeutics Key Players Head office and Area Served 3.4 Key Players Rotavirus Infection Therapeutics Product Solution and Service 3.5 Date of Enter into Rotavirus Infection Therapeutics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Rotavirus Infection Therapeutics Historic Market Size by Type (2015-2020) 4.2 Global Rotavirus Infection Therapeutics Forecasted Market Size by Type (2021-2026) 5 Rotavirus Infection Therapeutics Breakdown Data by Application (2015-2026) 5.1 Global Rotavirus Infection Therapeutics Market Size by Application (2015-2020) 5.2 Global Rotavirus Infection Therapeutics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Rotavirus Infection Therapeutics Market Size (2015-2020) 6.2 Rotavirus Infection Therapeutics Key Players in North America (2019-2020) 6.3 North America Rotavirus Infection Therapeutics Market Size by Type (2015-2020) 6.4 North America Rotavirus Infection Therapeutics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Rotavirus Infection Therapeutics Market Size (2015-2020) 7.2 Rotavirus Infection Therapeutics Key Players in Europe (2019-2020) 7.3 Europe Rotavirus Infection Therapeutics Market Size by Type (2015-2020) 7.4 Europe Rotavirus Infection Therapeutics Market Size by Application (2015-2020) 8 Asia-Pacific 8.1 Asia-Pacific Rotavirus Infection Therapeutics Market Size (2015-2020) 8.2 Rotavirus Infection Therapeutics Key Players in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Rotavirus Infection Therapeutics Market Size by Type (2015-2020) 8.4 Asia-Pacific Rotavirus Infection Therapeutics Market Size by Application (2015-2020) (2015-2020) (2015-2020) 9 Key Players Profiles 9.1 GlaxoSmithKline 9.1.1 GlaxoSmithKline Company Details 9.1.2 GlaxoSmithKline Business Overview and Its Total Revenue 9.1.3 GlaxoSmithKline Rotavirus Infection Therapeutics Introduction 9.1.4 GlaxoSmithKline Revenue in Rotavirus Infection Therapeutics Business (2015-2020)) 9.1.5 GlaxoSmithKline Recent Development 9.2 Bharat Biotech 9.2.1 Bharat Biotech Company Details 9.2.2 Bharat Biotech Business Overview and Its Total Revenue 9.2.3 Bharat Biotech Rotavirus Infection Therapeutics Introduction 9.2.4 Bharat Biotech Revenue in Rotavirus Infection Therapeutics Business (2015-2020) 9.2.5 Bharat Biotech Recent Development 9.3 Curevac 9.3.1 Curevac Company Details 9.3.2 Curevac Business Overview and Its Total Revenue 9.3.3 Curevac Rotavirus Infection Therapeutics Introduction 9.3.4 Curevac Revenue in Rotavirus Infection Therapeutics Business (2015-2020) 9.3.5 Curevac Recent Development 9.4 Ology Bioservices 9.4.1 Ology Bioservices Company Details 9.4.2 Ology Bioservices Business Overview and Its Total Revenue 9.4.3 Ology Bioservices Rotavirus Infection Therapeutics Introduction 9.4.4 Ology Bioservices Revenue in Rotavirus Infection Therapeutics Business (2015-2020) 9.4.5 Ology Bioservices Recent Development 9.5 BioKangtai 9.5.1 BioKangtai Company Details 9.5.2 BioKangtai Business Overview and Its Total Revenue 9.5.3 BioKangtai Rotavirus Infection Therapeutics Introduction 9.5.4 BioKangtai Revenue in Rotavirus Infection Therapeutics Business (2015-2020) 9.5.5 BioKangtai Recent Development 10 Analyst's Viewpoints/Conclusions 11 Appendix 11.1 Research Methodology 11.1.1 Methodology/Research Approach 11.1.2 Data Source 11.2 Disclaimer 11.3 Author Details

List of Tables Table 1. Rotavirus Infection Therapeutics Key Market Segments Table 2. Key Players Covered: Ranking by Rotavirus Infection Therapeutics Revenue Table 3. Ranking of Global Top Rotavirus Infection Therapeutics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Rotavirus Infection Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Oral Drug Table 6. Key Players of Injiectable Drug Table 7. COVID-19 Impact Global Market: (Four Rotavirus Infection Therapeutics Market Size Forecast Scenarios) Table 8. Opportunities and Trends for Rotavirus Infection Therapeutics Players in the COVID-19 Landscape Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 10. Key Regions/Countries Measures against Covid-19 Impact Table 11. Proposal for Rotavirus Infection Therapeutics Players to Combat Covid-19 Impact Table 12. Global Rotavirus Infection Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global Rotavirus Infection Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global Rotavirus Infection Therapeutics Market Size by Regions (2015-2020) (US$ Million) Table 15. Global Rotavirus Infection Therapeutics Market Share by Regions (2015-2020) Table 16. Global Rotavirus Infection Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global Rotavirus Infection Therapeutics Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. Rotavirus Infection Therapeutics Market Growth Strategy Table 22. Main Points Interviewed from Key Rotavirus Infection Therapeutics Players Table 23. Global Rotavirus Infection Therapeutics Revenue by Players (2015-2020) (Million US$) Table 24. Global Rotavirus Infection Therapeutics Market Share by Players (2015-2020) Table 25. Global Top Rotavirus Infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rotavirus Infection Therapeutics as of 2019) Table 26. Global Rotavirus Infection Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Rotavirus Infection Therapeutics Product Solution and Service Table 29. Date of Enter into Rotavirus Infection Therapeutics Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Rotavirus Infection Therapeutics Market Size by Type (2015-2020) (Million US$) Table 32. Global Rotavirus Infection Therapeutics Market Size Share by Type (2015-2020) Table 33. Global Rotavirus Infection Therapeutics Revenue Market Share by Type (2021-2026) Table 34. Global Rotavirus Infection Therapeutics Market Size Share by Application (2015-2020) Table 35. Global Rotavirus Infection Therapeutics Market Size by Application (2015-2020) (Million US$) Table 36. Global Rotavirus Infection Therapeutics Market Size Share by Application (2021-2026) Table 37. North America Key Players Rotavirus Infection Therapeutics Revenue (2019-2020) (Million US$) Table 38. North America Key Players Rotavirus Infection Therapeutics Market Share (2019-2020) Table 39. North America Rotavirus Infection Therapeutics Market Size by Type (2015-2020) (Million US$) Table 40. North America Rotavirus Infection Therapeutics Market Share by Type (2015-2020) Table 41. North America Rotavirus Infection Therapeutics Market Size by Application (2015-2020) (Million US$) Table 42. North America Rotavirus Infection Therapeutics Market Share by Application (2015-2020) Table 43. Europe Key Players Rotavirus Infection Therapeutics Revenue (2019-2020) (Million US$) Table 44. Europe Key Players Rotavirus Infection Therapeutics Market Share (2019-2020) Table 45. Europe Rotavirus Infection Therapeutics Market Size by Type (2015-2020) (Million US$) Table 46. Europe Rotavirus Infection Therapeutics Market Share by Type (2015-2020) Table 47. Europe Rotavirus Infection Therapeutics Market Size by Application (2015-2020) (Million US$) Table 48. Europe Rotavirus Infection Therapeutics Market Share by Application (2015-2020) Table 49. Asia-Pacific Key Players Rotavirus Infection Therapeutics Revenue (2019-2020) (Million US$) Table 50. Asia-Pacific Key Players Rotavirus Infection Therapeutics Market Share (2019-2020) Table 51. Asia-Pacific Rotavirus Infection Therapeutics Market Size by Type (2015-2020) (Million US$) Table 52. Asia-Pacific Rotavirus Infection Therapeutics Market Share by Type (2015-2020) Table 53. Asia-Pacific Rotavirus Infection Therapeutics Market Size by Application (2015-2020) (Million US$) Table 54. Asia-Pacific Rotavirus Infection Therapeutics Market Share by Application (2015-2020) Table 55. GlaxoSmithKline Company Details Table 56. GlaxoSmithKline Business Overview Table 57. GlaxoSmithKline Product Table 58. GlaxoSmithKline Revenue in Rotavirus Infection Therapeutics Business (2015-2020) (Million US$) Table 59. GlaxoSmithKline Recent Development Table 60. Bharat Biotech Company Details Table 61. Bharat Biotech Business Overview Table 62. Bharat Biotech Product Table 63. Bharat Biotech Revenue in Rotavirus Infection Therapeutics Business (2015-2020) (Million US$) Table 64. Bharat Biotech Recent Development Table 65. Curevac Company Details Table 66. Curevac Business Overview Table 67. Curevac Product Table 68. Curevac Revenue in Rotavirus Infection Therapeutics Business (2015-2020) (Million US$) Table 69. Curevac Recent Development Table 70. Ology Bioservices Company Details Table 71. Ology Bioservices Business Overview Table 72. Ology Bioservices Product Table 73. Ology Bioservices Revenue in Rotavirus Infection Therapeutics Business (2015-2020) (Million US$) Table 74. Ology Bioservices Recent Development Table 75. BioKangtai Company Details Table 76. BioKangtai Business Overview Table 77. BioKangtai Product Table 78. BioKangtai Revenue in Rotavirus Infection Therapeutics Business (2015-2020) (Million US$) Table 79. BioKangtai Recent Development Table 80. Research Programs/Design for This Report Table 81. Key Data Information from Secondary Sources Table 82. Key Data Information from Primary Sources List of Figures Figure 1. Global Rotavirus Infection Therapeutics Market Share by Type: 2020 VS 2026 Figure 2. Oral Drug Features Figure 3. Injiectable Drug Features Figure 4. Global Rotavirus Infection Therapeutics Market Share by Application: 2020 VS 2026 Figure 5. Hospital Pharmacies Case Studies Figure 6. Retail Pharmacies Case Studies Figure 7. Online Pharmacies Case Studies Figure 8. Rotavirus Infection Therapeutics Report Years Considered Figure 9. Global Rotavirus Infection Therapeutics Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Rotavirus Infection Therapeutics Market Share by Regions: 2020 VS 2026 Figure 11. Global Rotavirus Infection Therapeutics Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Rotavirus Infection Therapeutics Market Share by Players in 2019 Figure 14. Global Top Rotavirus Infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rotavirus Infection Therapeutics as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Rotavirus Infection Therapeutics Revenue in 2019 Figure 16. North America Rotavirus Infection Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Rotavirus Infection Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Asia-Pacific Rotavirus Infection Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 19. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 20. GlaxoSmithKline Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2015-2020) Figure 21. Bharat Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 22. Bharat Biotech Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2015-2020) Figure 23. Curevac Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Curevac Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2015-2020) Figure 25. Ology Bioservices Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Ology Bioservices Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2015-2020) Figure 27. BioKangtai Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. BioKangtai Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2015-2020) Figure 29. Bottom-up and Top-down Approaches for This Report Figure 30. Data Triangulation Figure 31. Key Executives Interviewed

GlaxoSmithKline Bharat Biotech Curevac Ology Bioservices BioKangtai